NewsWorld Health Organization4 min read
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients

In short
Clinical trials in the United Kingdom evaluated the corticosteroid dexamethasone for critically ill COVID-19 patients. The preliminary findings indicate the treatment significantly reduces mortality rates for individuals requiring oxygen and ventilator support.
Pro library
The three takeaways, why it matters for your work, and adding it to your page.
Studies, reports and articles picked for your craft every week, the full library, and a learning log on your page that shows your skills growing.
Black Friday price: $30 for 6 months, then $39 from 1 December. One payment, nothing renews.
Or read this week’s free picks →Read the original (free) at World Health Organization